+66
Abbott Labs
For individuals with diabetes and their caregivers requiring real-time glucose data and trend analysis.
Known for
For individuals with diabetes and their caregivers requiring real-time glucose data and trend analysis.
Providing digital health tools for continuous glucose monitoring. Enabling patients to track glucose trends via smartphone integration.
Target audience
Portfolio
Free 69Last updated
Libre by Abbott
v1.2.1
6mo ago
Primary focus
Medical device companion apps for glucose monitoring
Scale
indie
Target audience
Individuals with diabetes and their caregivers requiring real-time glucose data and trend analysis.
Released 4 updates across 3 apps in the last 6 months, maintaining a consistent focus on their core medical monitoring suite.
69 apps analysed
Analysis in progress
Analysis in progress
Analysis in progress
Analysis in progress
Analysis in progress
Single-market publisher — every app ships only to United States.
Based on 6 of 69 apps with localized market data — more coverage rolling in as scans complete · last scanned .
0
Positive apps
1
Neutral / mixed
1
Negative apps
30/100
Avg sentiment score
As a direct competitor in the CGM hardware space, Dexcom G7 is the primary alternative for users choosing between sensor ecosystems.
Strategic outlook coming soon.
What fed this analysis
With over 134,000 reviews and a high release cadence, mySugr is the primary competitor for user engagement in the diabetes management space.
A long-standing competitor in the diabetes space with a massive user base and high-quality clinical data visualization.
A veteran tracker that serves as a strong alternative for users who prioritize manual logging and community support.
The leading hardware-agnostic aggregator that positions itself as the 'universal' dashboard for clinical data sharing.
A full-stack health platform that combines hardware, software, and human coaching into a single subscription model.
High-utility medical app that demonstrates how to successfully pair hardware with a high-engagement mobile interface.
A personality-driven overlay for CGM data designed to reduce 'diabetes burnout' through humor.
A critical ecosystem player for users on automated insulin delivery (AID) systems.
Adjacent medical utility that focuses on medication adherence, a critical secondary need for diabetic patients.
A power-user tool that provides advanced visualization and cross-device syncing for CGM data.
A rising threat focusing on 'Collaborative Care' with a high update frequency in early 2026.
Rapidly evolving platform that bridges the gap between digital tracking and direct access to clinical care.
An AI-first companion that solves the 'carb counting' pain point which the target app leaves to manual entry.
High-velocity release cadence indicates an aggressive push into AI-driven personalized health coaching.
